H5 influenza mRNA vaccine candidate (second generation)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for H5 influenza mRNA vaccine candidate (second generation), covering 2026-01-16 to 2026-01-16. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and Older [Phase 1, Phase 2]